What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001835943
Total reported value
$1.6B
$1.6B
35 檔
5.3%
As reported in its official Q2 2025 Form 13F filing, AIGH Capital Management LLC's tracked investment portfolio stood at $1.6B with 35 total positions.
In Q2 2025, AIGH Capital Management LLC adopted a defensive or profit-taking posture, trimming 14 positions and completely liquidating 9 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PSNL | Personalis Inc | Stock-Other | 10.99% | -1.07% | -6.17% | |
| 2 | DOMO | Domo Inc - Class B | Stock-Other | 8.43% | +0.57% | NEW | |
| 3 | SCPH | Scpharmaceuticals Inc | Stock-Other | 6.63% | — | -5.59% | |
| 4 | ARQ | Arq Inc | Stock-Other | 6.41% | — | -4.18% | |
| 5 | VPG | Vishay Precision Group | Stock-Other | 5.35% | — | +60.68% | |
| 6 | LASR | Nlight Inc | Stock-Other | 5.31% | -2.64% | EXIT | |
| 7 | LPTH | Lightpath Technologies Inc-a | Stock-Other | 5.05% | -0.14% | EXIT | |
| 8 | BLZE | Backblaze Inc-a | Stock-Other | 4.48% | — | +5.65% | |
| 9 | GLW | Corning Inc | Stock-Tech | 4.14% | — | — | |
| 10 | VSTM | Verastem Inc | Stock-Other | 3.74% | -0.99% | -14.31% | |
| 11 | ZVRA | Zevra Therapeutics Inc | Stock-Other | 3.64% | -1.53% | EXIT | |
| 12 | MYO | Myomo Inc | Stock-Other | 3.45% | — | +22.33% | |
| 13 | ELVA | Electrovaya Inc | Stock-Other | 3.31% | — | -4.71% | |
| 14 | ALNT | Allient Inc | Stock-Other | 3.27% | — | — | |
| 15 | ELUT | Elutia Inc | Stock-Other | 3.07% | -0.34% | +2.06% | |
| 16 | COYA | Coya Therapeutics Inc | Stock-Other | 2.86% | -0.29% | -6.60% | |
| 17 | HRTX | Heron Therapeutics Inc | Stock-Other | 2.80% | — | +8.32% | |
| 18 | TQ80 | Theratechnologies Inc | Stock-Other | 2.21% | — | -10.49% | |
| 19 | ANGO | Angiodynamics Inc | Stock-Other | 2.12% | — | — | |
| 20 | RNXT | Renovorx Inc | Stock-Other | 2.05% | -0.23% | — | |
| 21 | ✓ | Polypid LTD | Stock-Other | 1.90% | -0.47% | +26.98% | |
| 22 | FENC | Fennec Pharmaceuticals Inc | Stock-Other | 1.69% | +0.02% | +25.32% | |
| 23 | GRCE | Grace Therapeutics Inc | Stock-Other | 1.51% | — | -14.66% | |
| 24 | IPWR | Ideal Power Inc | Stock-Other | 1.36% | -0.16% | -18.29% | |
| 25 | AMPG | Amplitech Group Inc | Stock-Other | 0.86% | — | — | |
| 26 | KALAEUR | Kala Bio Inc | Stock-Other | 0.64% | — | +52.79% | |
| 27 | NRXS | Neuraxis Inc | Stock-Other | 0.44% | -0.16% | +1913.19% | |
| 28 | APRE | Aprea Therapeutics Inc | Stock-Other | 0.41% | -0.06% | — | |
| 29 | IDN | Intellicheck Inc | Stock-Other | 0.37% | -1.45% | EXIT | |
| 30 | ✓ | Stock-Other | 0.32% | — | — | ||
| 31 | BFRI | Biofrontera Inc | Stock-Other | 0.31% | -0.06% | +33.10% | |
| 32 | KPRX | Kiora Pharmaceuticals Inc | Stock-Other | 0.28% | — | -14.68% | |
| 33 | FKWL | Franklin Wireless CORP | Stock-Other | 0.26% | — | -63.75% | |
| 34 | SMTK | Smartkem Inc | Stock-Other | 0.20% | -0.03% | EXIT | |
| 35 | INAB | In8bio Inc | Stock-Other | 0.14% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DOMO | Domo Inc - Class B | +6% | +78.49% | Add |
| 2 | LASR | Nlight Inc | +5.3% | NEW | New buy |
| 3 | PSNL | Personalis Inc | +5.2% | -6.17% | Trim |
| 4 | ALNT | Allient Inc | +3.3% | NEW | New buy |
| 5 | VPG | Vishay Precision Group | +2.7% | +60.68% | Add |
| 6 | SCPH | Scpharmaceuticals Inc | +2.2% | -5.59% | Trim |
| 7 | LPTH | Lightpath Technologies Inc-a | +2% | -1.10% | Trim |
| 8 | ARQ | Arq Inc | +1.6% | -4.18% | Trim |
| 9 | ELVA | Electrovaya Inc | +1.1% | -4.71% | Trim |
| 10 | BLZE | Backblaze Inc-a | +1.1% | +5.65% | Add |
| 11 | TQ80 | Theratechnologies Inc | +0.9% | -10.49% | Trim |
| 12 | ✓ | Polypid LTD | +0.8% | +26.98% | Add |
| 13 | GLW | Corning Inc | +0.8% | — | Unchanged |
| 14 | FENC | Fennec Pharmaceuticals Inc | +0.8% | +25.32% | Add |
| 15 | RNXT | Renovorx Inc | +0.6% | — | Unchanged |
| 16 | NRXS | Neuraxis Inc | +0.4% | +1913.19% | Add |
| 17 | AMPG | Amplitech Group Inc | +0.3% | — | Unchanged |
| 18 | ANGO | Angiodynamics Inc | +0.3% | — | Unchanged |
| 19 | HRTX | Heron Therapeutics Inc | +0.3% | +8.32% | Add |
| 20 | GRCE | Grace Therapeutics Inc | +0.3% | -14.66% | Trim |
| 21 | KALAEUR | Kala Bio Inc | +0.2% | +52.79% | Add |
| 22 | INAB | In8bio Inc | +0.1% | NEW | New buy |
| 23 | BFRI | Biofrontera Inc | +0.1% | +33.10% | Add |
| 24 | ✓ | 0% | — | Unchanged | |
| 25 | KPRX | Kiora Pharmaceuticals Inc | 0% | -14.68% | Trim |
| 26 | APRE | Aprea Therapeutics Inc | -0.1% | — | Unchanged |
| 27 | INABEUR | In8bio Inc | -0.1% | EXIT | Sold out |
| 28 | SMTK | Smartkem Inc | -0.2% | +50.40% | Add |
| 29 | COYA | Coya Therapeutics Inc | -0.3% | -6.60% | Trim |
| 30 | IPWR | Ideal Power Inc | -0.4% | -18.29% | Trim |
| 31 | ELUT | Elutia Inc | -0.5% | +2.06% | Add |
| 32 | APPS | Digital Turbine Inc | -0.5% | EXIT | Sold out |
| 33 | FKWL | Franklin Wireless CORP | -0.7% | -63.75% | Trim |
| 34 | TELA | Tela Bio Inc | -0.7% | EXIT | Sold out |
| 35 | ZVRA | Zevra Therapeutics Inc | -0.8% | -36.10% | Trim |
| 36 | ✓ | Biodesix Inc | -1.1% | EXIT | Sold out |
| 37 | DCTH | Delcath Systems Inc | -1.4% | EXIT | Sold out |
| 38 | IDN | Intellicheck Inc | -1.6% | -90.35% | Trim |
| 39 | VSTM | Verastem Inc | -2.1% | -14.31% | Trim |
| 40 | AKBA | Akebia Therapeutics Inc | -2.3% | EXIT | Sold out |
| 41 | MYO | Myomo Inc | -2.3% | +22.33% | Add |
| 42 | IWM | Ishares Russell 2000 ETF | -3.3% | EXIT | Sold out |
| 43 | BKTI | Bk Technologies CORP | -4.4% | EXIT | Sold out |
| 44 | QQQ | Invesco Qqq Trust Series 1 | -13.6% | EXIT | Sold out |
According to official SEC Form 13F filings, AIGH Capital Management LLC reported a total U.S. public equity portfolio value of $1.6B across 35 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PSNL, DOMO, SCPH) accounted for 5.3% of total reported equity market value during Q2 2025.
Top New Position Initiated
LASR
市值: $11.8M
Top Position Liquidated / Trimmed
QQQ
前期市值: $32.8M
During Q2 2025, AIGH Capital Management LLC's top holdings by market value included PSNL (11.0%)、DOMO (8.4%)、SCPH (6.6%). The largest single position, PSNL, represented 11.0% of total portfolio value.
In Q2 2025, AIGH Capital Management LLC made 38 total portfolio adjustments, initiating 3 new buys, adding to 12 positions, trimming 14 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.